Regardless of who we are and where we live and come from, we all must have looked at the sky at least once and wondered:
What is Space Travel and Exploration?
Space travel and exploration is not a new endeavor. Our parents and grandparents saw a huge step for humankind when we landed on the Moon decades ago. However, there is renewed interest in the last few years and a focus on pushing the space travel frontier and becoming a multi-planetary species. Numerous startups have emerged in the private market, and many public companies have focused on space travel. A new industry has been born from creating reusable rockets to making space travel more affordable and enabling unmanned exploration vehicles to prepare for humans' arrival.
We started our research by identifying direct exploration and space travel companies. Such companies manufacture probes, rockets, and unmanned robots to use on other planets. From there, we extended our research to space travel enablers who create the necessary tools, hardware, and software for such exploration. Solutions such as ground-based operations to support the interstellar missions, highly advanced materials for outer space usage are excellent examples of space travel and exploration enablers. In the end, we summarized the world of Space Travel and Exploration into four subsegments:
The result of our research is now available to you on Stock Card's Featured tab. You will find 49 companies in this collection pushing humanity for its next leap, working in areas where most investors have never assumed possible.
As always, you are investing in future-shaping companies that come with an inherent risk. Many smaller companies focused on space exploration, and travel are unprofitable. Some haven't yet turned a single dollar in revenue, and the larger ones would still need billions of dollars in investment before making money from space travel and exploration. Should you choose to invest in stocks from Space Travel and Exploration, make sure to go for cash-rich companies with substantial competitive advantages. Those are some of the criteria that would protect your investment even if the sector goes through the typical stock market ebbs and flows.
Investing in biotechnology companies that focus on the fight against COVID-19 involves understanding four main components: diagnostics, cure, vaccine, and distribution. More than 100 companies are competing in the vaccine development race, and several others are already getting ready to produce and distribute it. However, to contain the spread, diagnostic testing is an important frontier as the vaccine development is. As always, what becomes a society's priority tends to become a noteworthy investment too. This week, we turn our focus on COVID-19 Testing Kit stocks to give StockCardians and our broader community a starting point for their fight against COVID-19, investing-style.
The overall process of diagnostic testing depends on several different products such as swabs, glass vials, RT-PCR testing machines, a laboratory apparatus most commonly in DNA segmenting via the polymerase chain reaction (PCR), electronic or disposable pipettes, filter tips, and refrigerated microcentrifuges. To those products, one can add services such as test sample transportation and imaging centers. To build a robust list of companies involved in manufacturing testing kits and distribute diagnostic testing, we first referred to Stock Card’s proprietary market database to look for diagnostic testing companies. We then validated the list with holdings of exchange-traded funds such as the GERM ETF, which seeks to track the Prime Treatments, Testing, and Advancements Index.
Because of the priority and popularity of the COVID-19- related topics, almost every pharmaceutical, and healthcare company associate its operations with developing a testing kit, vaccine, or cure. However, the tricky part of the research was to screen for companies that are much more committed to finding the cure, assisting with diagnostics, and producing materials needed for various efforts in the COVID-19 ecosystem and are achieving early success. Our analyst team spent more than two weeks evaluating the list qualitatively, and the result has turned out to be a reliable yet robust list of companies worthy of your attention.
Risk and opportunity
As always, when you invest in companies without a proven track record of product and financial success, it involves risk. The risk is exacerbated when dealing with biotechnology companies in the COVID-19 ecosystem of vaccine and testing kits developments and has no other revenue sources. Your investment success would have two possible extreme outcomes. Either the company succeeds, and you win with it. Or, despite all the efforts and stock price volatility, the investment loses all its value. A binary result is the most typical risk you'd need to be ready to face, should you choose to invest in the COVID-19 testing kit stocks. The evidence of such binary outcome is visible in the rapid decline of the stock prices of testing kit frontrunners such as Quidel, Hologic, and Quest Diagnostics, since the launch of the low-cost testing kit by Abbot.
While that's a substantial risk, it may also mean an opportunity. It is worth evaluating some of the beaten-down testing kits stocks to find well-managed companies that are not purely reliant on a testing kit's success and can recover into more reasonable valuation in the future.
After the thorough research and curation of the list, we identified more than 80 companies involved in producing the COVID-19 testing kits and providing diagnostic testing services. You can access them directly by clicking on the below button. Alternatively, type in "COVID-19 testing kit" in the search bar, and you get the list.
Investing in promising innovations that can potentially shape the future could be one of the best long-term investment strategies. One prominent example is the Electric Vehicles market. Electric vehicles date back to the 1830s when the first generation of eco-friendly cars came about. Later on, companies like Tesla brought the technology into the limelight and made it somewhat affordable for mass production. Since then, the wave of fuel-efficient and low-emission cars has spread to all types of vehicles, including heavy trucks and trains, and the technology has even spread to adjacent markets such as electric spacecraft!
To become a part of such an innovative market, one can invest in the growing electric vehicle companies for several years and benefit from the long-term price appreciation. How do you find such companies, especially those that are not yet well-known but are developing the critical components of this truly future-defining industry?
When we say "electric vehicles," one would almost immediately think of Tesla! However, even though Tesla is one of the leading companies in this market, some well-established automakers such as Volkswagen, BMW, and Nissan, have entered into this new market as competitors. And, the story doesn't stop there. Who builds the batteries, the software, and other components that enable this industry?
To answer that question, Stock Card team (Shama Patwardhan, Head of LiveOps and Raj Arora, Research Analyst Intern) dug deep into the industry and identified the companies that are enabling the “Electric Vehicles” to evolve and grow.
Our research methodology
Investing in the electric vehicles industry is not limited to just EV manufacturing companies. A large number of companies support the supply chain, which qualifies them as potential investment choices. Investors may find hidden gems among these lesser-known companies.
We began our research by mapping all of the different markets associated with the electric vehicles manufacturing process. We looked at the various components manufacturers, electric car charging businesses, lithium-ion technology-based battery manufacturing companies, lithium miners, and software development that powers electric self-driving cars. Here are a few markets associated with the “Electric Vehicles” collection:
As we wrapped up our research on electric vehicles, we discovered close to 100 companies that belong to the "Electric Vehicles" collection.
Before jumping in, let's remember that this market is still relatively new, and investing in rapidly evolving but new technologies come with inherent investment risks. For instance, manufacturing electric vehicles requires a significant investment in the infrastructure, which may get delayed or impact investors' short-term returns. Moreover, several companies on this list are still in the early stage and do not have a commercial product (e.g., Nikola Corp). Investors may need to stay invested and be patient with their investment through several possible volatile periods before the investment pans out.
Keep those risks in mind and explore our new "Electric Vehicles" collection to discover investment-worthy companies to add to your watch-lists and portfolios
Disclaimer: Stock Card team owns shares of Tesla.
The Coronavirus pandemic engulfed the whole world at the beginning of 2020, bringing all economies to a standstill. Offices and stores closed down to prevent the spread of the virus. Developing, producing, and distributing a cure and vaccine to immunize the world population became a race many pharmaceutical companies have embarked on. Consequently, media, investors, and traders have been speculating, discussing, and pouring money into those pharmaceutical companies. The hope for a vaccine has fueled unprecedented market volatility we have rarely seen in the recent market history. After all, there is a race going on, the race to COVID-19 vaccine.
The launch of "COVID-19 Vaccine Race" collection
In May 2020, the United States government introduced a framework for 'Operation Warp Speed,' a national program to accelerate the development, production, and distribution of COVID-19 vaccines. The program aims to have the vaccines ready by January 2021. More than 100 biotech companies began investing in the development of vaccines for the COVID-19 virus in the first quarter of 2020. According to the Federal Drug Administration, as of June 2020, there have been approvals to more than 25 companies to fast track the development and testing of their vaccines. And, another 141 companies are still in the development phase.
Our research methodology
As always, the Stock Card team took on researching the most viable investment opportunities that our users and community must add to their watchlist, if they plan to participate in the race to the vaccine. We investigated different activities that support the development, production, and distribution of a vaccine and added a list of companies involved in the process to our collections and themes. This list enables you to discover promising companies to invest in easily should you choose to participate in the race to the vaccine.
To create the "COVID-19 Vaccine Race" collection, a lot of research went into understanding the whole process involved in the end-to-end development of the vaccine, and the pre- and post-vaccine steps required in the process. We identified all the industries and markets which play crucial roles in making the vaccine a success. For example, one of the primary core markets is the vaccine components and raw materials. Our research found a high demand for vaccine adjuvants, which are essential in any vaccine. Few other markets that are discussed less frequently but are as important as the vaccine development are the companies involved in the vaccine production, including glass vials, cold chain logistics, and syringes, and needles. Therefore, the race to a vaccine isn't only about Vaccine development and encompasses an entire ecosystem of companies working together to take the global population to immunity destination.
Here's a list of the primary markets vital to the vaccine development and distribution:
In the race to the COVID-19 vaccine, the competition between companies is fierce as all companies strive to win. We put together a list of 60 companies, accelerating their development to win the race. Some of these companies may be very small but watchlist-worthy. Some are large and stable, with several products already in the market. Start your research by visiting Stock Card's COVID-19 Vaccine Race collection. You can always add additional filters to narrow down the list to your portfolio's most suitable stocks.
The outbreak of Coronavirus has changed the way we live and work dramatically. The impact is not limited to people having masks on, and sitting 6 feet apart. The more prominent but less visible change is the transition of work from offices and commercial physical spaces to our homes. Working from home is not just limited to having a desk set-up, although that's certainly a necessity. The more critical enabler of the working-from-home era is digital infrastructure, such as a smoother log-in and access to the tools employees need to do their job. The more digital works become, the more significant is the need for easier online communications, document management, payment, and cybersecurity. Such a simultaneous and rapid shift to a new way of working has boosted companies' growth prospects associated with "work-from-home" products. At Stock Card, we live by the belief that our investment is a financial image of our lives, and it was only a matter of time before we completed our research to introduce a new list of companies that enable the work-from-home era.
Launching Stock Card's "Work-From-Home" collection
Last week, we introduced a collection called "Companies Shaping the Future." Many users told us that it helped them discover new growing companies to add to their portfolios. We hope the new "work-from-home" collection does the same. To build this list, we picked themes and markets associated with making "work-from-home" possible, less expensive, and more reliable. We have included companies from 40 different markets to create this new list. Some of these markets are:
You can click on the above links to see the individual market collections.
The above screening gave us a list of 450 companies as a starting point for your research. The best way to use this new collection is to look it up in the search bar, use the "advanced filters" to add your criteria and get a list of stocks that fit your investment goal. The video below shows you how, or click here to get the full list...
If you don't have a brokerage account to invest in Work-From-Home stocks, here is one of the best. We like the M1 Finance app that has an easy-to-use interface. Give it a try if you are in the market for a new brokerage account: